Skip to main content
OpenTrials
Completed

NCT Number: NCT00816608

The Effect of Maximum Body Weight in Lifetime on the Development of Type 2 Diabetes

Hypothesis : The maximum body weight in lifetime is associated with the onset of development of type 2 diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Bundang Hospital

Seongnam, Bundang-gu, 463-707, South Korea

About this study

Obesity is well recognized risk factor for type 2 diabetes. Recent studies reported that weight change, especially severe weight gain was associated with an increased risk of type 2 diabetes. The aim of this study is to investigate whether the maximum body weight of lifetime is associated with the early onset of type 2 diabetes or an increased risk of type 2 diabetes in Korean.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Korean with type 2 diabetes
  • Korean with confirmed IFG or IGT
  • Korean with NGT

Exclusion criteria

  • Malignancy except thyroid cancer
  • Active tuberculosis

Treatment and study plan

Primary outcomes

  1. The development of diabetes

    Time frame: Five years

Secondary outcomes

  1. DM complication

    Time frame: 5 years

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Official study title

Study of MAXimum Weight in Lifetime on Glucose Homeostasis (MAXWEL)

Acronym: MAXWEL

Important dates

Study start
2006
Primary completion
2012
Study completion
2013
First posted
Jan 1, 2009
Registry last updated
Oct 25, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.